Karuna Therapeutics, Inc. (NASDAQ:KRTX)

About the company

Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders.The company was founded in July 2009 by Andrew Miller, Eric Elenko and Peter Jeffrey Conn and is headquartered in Boston, MA.

Sector

Health Technology

Industry

Pharmaceuticals: Major

Employees

19

CEO

Steven Marc Paul

Exchange

NASDAQ

Website

http://www.karunatx.com

$NoneM

Total Revenue

19

Employees

$3B

Market Capitalization

-68.24

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Johnson & Johnson JNJ 377376.69 82729.00 6.06 21.99 20.75
Merck & Co., Inc. MRK 202149.48 48081.00 7.59 19.94 21.10
Pfizer Inc. PFE 194670.90 50660.00 2.95 12.32 31.17
Eli Lilly & Co. LLY 150432.66 23087.00 51.05 26.52 23.97
AbbVie, Inc. ABBV 147123.76 34057.00 -23.55 17.55 24.65
Bristol Myers Squibb Co. BMY 110414.38 31006.00 2.68 93.87 3.08
Repligen Corp. RGEN 6459.15 286.00 6.19 281.44 8.11
Reata Pharmaceuticals, Inc. RETA 4893.35 20.00 23.18 -15.74 -150.30
Nektar Therapeutics NKTR 4139.52 137.00 3.23 -9.01 -335.62
Biohaven Pharmaceutical Holding Co. Ltd. BHVN 3702.40 1.00 34.23 -5.66 None
Allakos, Inc. ALLK 3144.30 None 6.83 -33.62 None
Karuna Therapeutics, Inc. KRTX 2767.96 None 7.23 -68.24 None
ADC Therapeutics SA ADCT 2756.70 2.00 32.52 -23.63 None
Turning Point Therapeutics, Inc. TPTX 2316.60 None 6.97 -19.38 None
IGM Biosciences, Inc. IGMS 2230.14 None 9.83 -41.11 None
Apellis Pharmaceuticals, Inc. APLS 2175.36 None 9.61 -5.22 None
OPKO Health, Inc. OPK 2155.86 891.00 1.53 -7.37 -32.92
Ra Pharmaceuticals, Inc. RARX 2111.78 3.00 8.68 -20.78 -585.71
Springworks Therapeutics, Inc. SWTX 1743.65 None 5.66 -27.97 None
Principia Biopharma, Inc. PRNB 1568.00 30.00 5.58 -22.31 -242.01
Y-mAbs Therapeutics, Inc. YMAB 1551.78 None 9.51 -16.84 None
Zymeworks, Inc. ZYME 1514.94 26.00 3.14 -8.93 -629.37
Akcea Therapeutics, Inc. AKCA 1370.61 341.00 2.81 -48.72 -8.59
Kiniksa Pharmaceuticals Ltd. KNSA 1305.15 None 6.76 -10.79 None
Tricida, Inc. TCDA 1298.01 None 6.67 -6.15 None
Arcutis Biotherapeutics, Inc. ARQT 1184.37 None 5.05 -18.94 None
Odonate Therapeutics, Inc. ODT 1163.48 None 9.53 -10.34 None
Athenex, Inc. ATNX 1070.16 123.00 6.56 -9.94 -87.86
Phibro Animal Health Corp. PAHC 1068.87 818.00 5.40 28.97 4.49
Akero Therapeutics, Inc. AKRO 957.58 None 8.00 -18.87 None
Constellation Pharmaceuticals, Inc. CNST 927.36 None 3.86 -9.99 None
Oric Pharmaceuticals, Inc. ORIC 838.04 None -9.10 -27.71 None
G1 Therapeutics, Inc. GTHX 818.52 1.00 3.54 -6.24 None
Gossamer Bio, Inc. GOSS 802.76 None 3.26 -4.04 None
Phathom Pharmaceuticals, Inc. PHAT 789.50 None 4.38 -2.90 None
Aprea Therapeutics, Inc. APRE 768.60 None 6.80 -22.73 None
Krystal Biotech, Inc. KRYS 760.75 None 4.44 -36.68 None
Quanterix Corp. QTRX 752.76 60.00 6.64 -17.21 -71.52
Applied Therapeutics, Inc. APLT 729.30 None 4.71 -14.80 None
Provention Bio, Inc. PRVB 669.94 None 10.60 -15.13 None
Provention Bio, Inc. PRVB 651.88 None 10.31 -14.72 None
Keros Therapeutics, Inc. KROS 644.40 8.00 -29.11 -30.34 -285.35
Amneal Pharmaceuticals, Inc. AMRX 619.24 1679.00 4.26 -2.84 -11.85
Arcturus Therapeutics Holdings, Inc. ARCT 605.28 19.00 56.10 -21.76 -151.34
Oyster Point Pharma, Inc. OYST 596.40 None 5.99 -10.36 None
Mirum Pharmaceuticals, Inc. MIRM 503.75 None 3.28 -7.44 None
SIGA Technologies, Inc. SIGA 489.54 19.00 5.48 -24.87 -94.00
Imara, Inc. IMRA 483.82 None 4.67 -13.75 None
Satsuma Pharmaceuticals, Inc. STSA 463.25 None 4.56 -12.73 None
Biospecifics Technologies Corp. BSTC 436.94 40.00 3.55 18.69 61.80
DURECT Corp. DRRX 416.64 28.00 32.00 -17.23 -82.94
Fulcrum Therapeutics, Inc. FULC 410.55 1.00 6.92 -5.95 None
Crinetics Pharmaceuticals, Inc. CRNX 406.56 1.00 5.13 -6.97 -447.78
Ocular Therapeutix, Inc. OCUL 396.48 6.00 -48.59 -4.32 None
89bio, Inc. ETNB 386.40 None 4.77 -5.99 None
Relmada Therapeutics, Inc. RLMD 385.02 0.00 5.74 -32.17 -877.66
Kala Pharmaceuticals, Inc. KALA 380.16 6.00 4.16 -4.14 None
TCR2 Therapeutics, Inc. TCRR 373.20 None 2.55 -37.02 None
Osmotica Pharmaceuticals Plc OSMT 349.38 232.00 2.65 -1.27 -115.44
Ovid Therapeutics, Inc. OVID 323.55 None 7.65 -4.96 None
Urovant Sciences Ltd. UROV 315.00 None -5.59 -2.18 None
Aeglea Biotherapeutics, Inc. AGLE 298.98 4.00 9.44 -3.73 -523.27
HOOKIPA Pharma, Inc. HOOK 280.28 13.00 2.54 -6.20 -333.02
IDEAYA Biosciences, Inc. IDYA 274.60 None 4.17 -6.30 None
AMAG Pharmaceuticals, Inc. AMAG 273.70 321.00 1.05 -0.74 -115.05
Lannett Co., Inc. LCI 270.56 542.00 0.92 -8.90 -5.77
Verrica Pharmaceuticals, Inc. VRCA 257.50 None 4.70 -8.44 None
Spero Therapeutics, Inc. SPRO 254.03 12.00 3.34 -3.12 -656.72
Gritstone Oncology, Inc. GRTS 236.88 4.00 2.12 -2.27 None
Kaleido Biosciences, Inc. KLDO 234.00 None 8.30 -3.20 None
KalVista Pharmaceuticals, Inc. KALV 233.46 12.00 2.58 -7.21 -263.38
Veru, Inc. VERU 218.40 39.00 7.30 -22.40 -25.53
LogicBio Therapeutics, Inc. LOGC 201.71 1.00 6.09 -4.74 None
Galera Therapeutics, Inc. GRTX 180.25 None 3.37 -2.74 None
Liquidia Technologies, Inc. LQDA 171.38 8.00 10.12 -3.48 -602.17
Sutro Biopharma, Inc. STRO 171.12 41.00 3.25 -2.81 -148.06
Protara Therapeutics, Inc. TARA 168.06 None 2.53 -10.90 None
Avenue Therapeutics, Inc. ATXI 167.52 532.00 30.79 -11.51 26.69
Evolus, Inc. EOLS 164.40 45.00 2.95 -1.62 -217.51
Evelo Biosciences, Inc. EVLO 160.96 None 4.12 -1.84 None
Cyclerion Therapeutics, Inc. CYCN 156.60 6.00 1.97 -1.51 None
Tyme Technologies, Inc. TYME 148.35 None 8.60 -6.79 None
Trevi Therapeutics, Inc. TRVI 138.42 None 2.94 -4.72 None
Harrow Health, Inc. HROW 137.28 51.00 8.80 -5.56 -47.54
scPharmaceuticals, Inc. SCPH 136.04 119.00 3.48 -4.34 -27.05
Lyra Therapeutics, Inc. LYRA 133.32 1.00 -1.13 -7.99 -491.16
Aquestive Therapeutics, Inc. AQST 131.88 49.00 -7.60 -1.88 -139.64
PhaseBio Pharmaceuticals, Inc. PHAS 127.31 2.00 2.36 -2.66 None
Mustang Bio, Inc. MBIO 122.40 None 2.86 -2.49 None
NeuBase Therapeutics, Inc. NBSE 121.24 None 50.94 -2.71 None
TFF Pharmaceuticals, Inc. TFFP 117.61 None 4.55 -3.03 None
Immunic, Inc. IMUX 117.40 None 3.45 -53.36 None
Ayala Pharmaceuticals, Inc. AYLA 116.64 3.00 -2.75 -5.65 -679.19
Eton Pharmaceuticals, Inc. ETON 99.36 1.00 10.82 -4.97 None
Milestone Pharmaceuticals, Inc. MIST 93.00 None 0.92 -1.49 None
Checkpoint Therapeutics, Inc. CKPT 79.60 2.00 6.86 -3.43 -949.53
EyePoint Pharmaceuticals, Inc. EYPT 79.57 26.00 5.62 -1.62 -196.30
Clearside Biomedical, Inc. CLSD 79.54 6.00 10.21 -4.51 -293.61
Xeris Pharmaceuticals, Inc. XERS 78.12 4.00 3.87 -0.60 None
Corvus Pharmaceuticals, Inc. CRVS 75.40 None 1.21 -1.60 None
Baudax Bio, Inc. BXRX 72.00 None -1.96 -1.03 None
Navidea Biopharmaceuticals, Inc. NAVB 68.34 1.00 -50.25 -6.18 -65.13
BiomX, Inc. PHGE 65.45 None 1.72 -1.53 None
Assertio Therapeutics, Inc. ASRT 59.04 192.00 1.02 -0.36 -83.99
Genprex, Inc. GNPX 57.57 None 4.89 -4.21 None
Aridis Pharmaceuticals, Inc. ARDS 56.97 1.00 -23.44 -1.95 -851.00
Menlo Therapeutics, Inc. MNLO 52.49 2.00 4.41 -0.56 -483.51
Aerpio Pharmaceuticals, Inc. ARPO 51.66 20.00 1.56 -2.74 -51.58
Eyenovia, Inc. EYEN 45.60 None 4.60 -2.23 None
Edesa Biotech, Inc. EDSA 44.82 0.00 6.38 -0.47 -395.23
Moleculin Biotech, Inc. MBRX 42.69 None 3.71 -4.64 None
Akari Therapeutics Plc AKTX 36.18 None -33.50 -2.01 None
Oncternal Therapeutics, Inc. ONCT 35.75 3.00 4.58 -1.42 -225.89
Allena Pharmaceuticals, Inc. ALNA 35.42 None 4.67 -0.81 None
Mannatech, Inc. MTEX 34.08 156.00 1.44 7.68 3.45
AgeX Therapeutics, Inc. AGE 33.78 2.00 -44.45 -2.78 -658.11
CNS Pharmaceuticals, Inc. CNSP 33.12 None 5.75 -6.09 None
Citius Pharmaceuticals, Inc. CTXR 32.94 None 2.44 -1.91 None
Acer Therapeutics, Inc. ACER 32.50 3.00 2.37 -1.25 -274.69
Aileron Therapeutics, Inc. ALRN 32.48 None 4.46 -1.22 None
Adamis Pharmaceuticals Corp. ADMP 31.32 22.00 1.20 -1.06 -140.33
Annovis Bio, Inc. ANVS 30.10 None 2.76 -23.89 None
Millendo Therapeutics, Inc. MLND 25.80 0.00 0.61 -0.55 None
Hoth Therapeutics, Inc. HOTH 25.00 None 6.94 -2.78 None
Spring Bank Pharmaceuticals, Inc. SBPH 23.20 0.00 0.88 -0.89 None
Akorn, Inc. AKRX 22.68 721.00 -1.20 -0.06 -55.64
Daré Bioscience, Inc. DARE 18.96 1.00 8.31 -1.13 None
ProPhase Labs, Inc. PRPH 16.80 9.00 1.52 -5.60 -31.15
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Teligent, Inc. TLGT 14.40 60.00 -0.49 -0.36 -71.80
Novan, Inc. NOVN 14.21 5.00 -3.27 -0.45 -602.34
Adial Pharmaceuticals, Inc. ADIL 13.80 None 3.37 -1.82 None
Titan Pharmaceuticals, Inc. TTNP 12.00 4.00 5.00 -0.67 -437.91
PDS Biotechnology Corp. PDSB 11.69 None 1.29 -0.46 None
Novus Therapeutics, Inc. NVUS 7.39 None 0.63 -0.35 None
Brickell Biotech, Inc. BBI 5.05 5.00 1.66 -0.07 -432.19
BioStar Pharmaceuticals, Inc. BSPM 0.21 0.00 0.01 0.10 294.01

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Hedge Funds Keep Buying Karuna Therapeutics, Inc. (KRTX)

5d ago, source: YAHOO!

Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire ...

BRIEF-Karuna Therapeutics Files For Potential Mixed Shelf Offering Size Not Disclosed

1d ago, source: Reuters

KARUNA THERAPEUTICS INC FILES FOR POTENTIAL MIXED SHELF OFFERING; SIZE NOT DISCLOSED - SEC FILING * KARUNA THERAPEUTICS INC - FILES FOR SHELF OF UP TO $150 MILLION SHARES OF COMMON STOCK Further compa ...

Karuna Therapeutics (NASDAQ:KRTX) CEO Steven M. Paul Sells 292,207 Shares

2d ago, source: theenterpriseleader.com

CEO Steven M. Paul sold 292,207 shares of the company’s stock in a transaction dated Monday, June 29th. The stock was sold at ...

BRIEF-Karuna Announces Positive Outcome Of End-Of-Phase 2 Meeting With FDA For Karxt For Schizophrenia

10d ago, source: Reuters

KARUNA THERAPEUTICS ANNOUNCES POSITIVE OUTCOME OF END-OF-PHASE 2 MEETING WITH THE FDA FOR KARXT FOR THE TREATMENT OF ACUTE PSYCHOSIS IN PATIENTS WITH SCHIZOPHRENIA * KARUNA THERAPEUTICS INC - ON TRACK ...

Karuna Program Progress, And Other News: The Good, Bad And Ugly Of Biopharma

8d ago, source: Seeking Alpha

Karuna's clinical program for acute psychosis is about to proceed. Corbus reports progress for its phase 2 program. Myovant reports positive data for relugolix.

Karuna Therapeutics Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA for KarXT for the Treatment of Acute Psychosis in Patients with Schizophrenia

11d ago, source: Business Wire

Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the pote ...

Karuna Therapeutics (NASDAQ:KRTX) Given “Buy” Rating at Mizuho

10d ago, source: modernreaders.com

Mizuho restated their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX) in a report released on Tuesday, TipRanks ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.